DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Author: Business Wire
Alcon Shareholders Approve All Proposed Resolutions at the 2020 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon shareholders approve all proposed resolutions at the 2020 Annual General Meeting
Alcon Shareholders Approve All Proposed Resolutions at the 2020 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon shareholders approve all proposed resolutions at the 2020 Annual General Meeting
Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that updated results from …
Leading North American and European Glaucoma Leaders Highlight Significant Effectiveness and Favorable Safety Profile of Excimer Laser Trabeculostomy in Review Article
LOS ANGELES & MUNICH–(BUSINESS WIRE)–Ten independent clinical studies demonstrate significant IOP lowering effect of ELT with few complications, no residual device remaining in the angle
Global Contact Lens Market: Insights, COVID-19 Impact, Competition and Forecast (2020-2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market – Analysis By Material (Silicone Hydrogel, Hydrogel, Hybrid, Others), Wear Type, Design, By Region, By Country (2020 Edition): Market Insight, COVID-19 Impact, Competition and Forecast (2020-2025…
IVERIC bio Reports First Quarter 2020 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced financial and operating results for the fiscal quarter ended March 31, 2020 and provided a general business update.
Global Optical Imaging Market Report to 2024 – Trends, Forecast and Competitive Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Imaging Market Report: Trends, Forecast, and Competitive Analysis” report has been added to ResearchAndMarkets.com’s offering. The future of the optical imaging market looks promising with opportunities in the hosp…
Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today annou…
Aerie Pharmaceuticals to Present at the Bank of America Securities 2020 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
National Vision Holdings, Inc. Announces First Quarter 2020 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its first quarter 2020 financial results before the market opens on Thursday, May 7, 2020. The Company will host a conference ca…
ZOLL TherOx Receives CE Mark Approval for SuperSaturated Oxygen Therapy
CHELMSFORD, Mass.–(BUSINESS WIRE)– #InterventionalCardiologist–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and d…
Wagner Macula & Retina Center Adopts Novel Technology to Protect Community Eye Health During the COVID-19 Pandemic
VIRGINIA BEACH, Va.–(BUSINESS WIRE)– #ai4healthcare–Eyenuk, Inc. announced today that it has partnered with Wagner Macula & Retina Center (WMRC), a leading research and treatment center specializing in diabetic retinopathy, macular degeneration,…
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio reported that it granted a newly hired, non-executive employee a non-statutory stock option to purchase 33,000 shares of common stock.
Kala Pharmaceuticals Resubmits New Drug Application for EYSUVIS™ for Dry Eye Disease
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it has resubmitte…
HORAMA Appoints Industry Veteran Ian Catchpole as Chief Scientific Officer
PARIS–(BUSINESS WIRE)–HORAMA appoints industry veteran Ian Catchpole as Chief Scientific Officer
Corneal Ulcer Report 2020: Pipeline Insights and Outlook – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Ulcer Pipeline Insight, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report outlays comprehensive insights of present clinical development scenario and growth prospects across the …
Bacterial Conjunctivitis 2020: Detailed Insights Into the Pipeline Landscape – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Bacterial Conjunctivitis – Pipeline Insight, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report outlays comprehensive insights of present clinical development scenario and growth prospect…
Choroideremia Pipeline Landscape Report 2020: Therapeutic Assessment, Unmet Needs, Products, Drugs, Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Choroideremia – Pipeline Insight, 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report outlays comprehensive insights of present clinical development scenario and growth prospects across th…
Second Sight Medical Products Announces Pricing of Public Offering of Common Stock
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today annou…